1. Home
  2. HNNA vs TLPH Comparison

HNNA vs TLPH Comparison

Compare HNNA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

N/A

Current Price

$10.00

Market Cap

79.2M

Sector

Finance

ML Signal

N/A

Logo Talphera Inc.

TLPH

Talphera Inc.

HOLD

Current Price

$1.23

Market Cap

70.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
TLPH
Founded
1989
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
70.3M
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
HNNA
TLPH
Price
$10.00
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
300.6K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
5.57%
N/A
EPS Growth
38.04
N/A
EPS
0.73
N/A
Revenue
$54,590,000.00
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.74
N/A
Revenue Growth
3.09
N/A
52 Week Low
$8.90
$0.50
52 Week High
$13.00
$1.57

Technical Indicators

Market Signals
Indicator
HNNA
TLPH
Relative Strength Index (RSI) 53.11 47.07
Support Level $9.67 $1.22
Resistance Level $10.29 $1.29
Average True Range (ATR) 0.12 0.08
MACD 0.01 -0.01
Stochastic Oscillator 52.46 30.77

Price Performance

Historical Comparison
HNNA
TLPH

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: